Construction of a novel radioresistance-related signature for prediction of prognosis, immune microenvironment and anti-tumour drug sensitivity in non-small cell lung cancer
Our study developed an eight-gene risk score model with potential clinical value that can be adopted for choice of drug treatment and prognostic prediction. Its clinical routine use may assist clinicians in selecting more rational practices for individuals, which is important for improving the prognosis of NSCLC patients. These findings also provide references for the development of potential therapeutic targets.
Authors
- Junjun Sun
- Chan Zhou (ORCID: https://orcid.org/0000-0002-0351-6235)
- Xiaoqiao Zhang (ORCID: https://orcid.org/0000-0002-1422-9709)
- Yanliang Chen (ORCID: https://orcid.org/0000-0003-0475-3774)
- Dandan Wang (ORCID: https://orcid.org/0000-0002-9370-0668)
- Min Chen (ORCID: https://orcid.org/0000-0002-0093-9056)
- Lisha Zhang (ORCID: https://orcid.org/0000-0003-4628-7978)
- Meifang Wang (ORCID: https://orcid.org/0000-0002-0086-412X)
- Litao Huang (ORCID: https://orcid.org/0009-0009-9547-9029)
Institutions
- Hubei University of Medicine (CN)
- Sichuan University (CN)
- West China Hospital of Sichuan University (CN)
- China National Pharmaceutical Group Corporation (China) (CN)
- Second Hospital of Tangshan (CN)
- Taihe Hospital (CN)
- Dongfeng General Hospital (CN)
- Lanzhou University (CN)
- Yangzhou University (CN)
Publication Details
- Journal
- Annals of Medicine
- Published
- 2025-01-10
- DOI
- https://doi.org/10.1080/07853890.2024.2447930
- Citations
- 5
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 4.03
Funders
- Natural Science Foundation of Jiangsu Province